An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
2025 · Nature Cancer · 23 citations
https://doi.org/10.1038/s43018-025-00950-1
Z
Zhichao Kong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
67
Citations
2
h-index
2
i10-index
Zhichao Kong is an academic researcher from Shandong University. The author has contributed to research in topics: Alzheimer's disease research and treatments & Neuroinflammation and Neurodegeneration Mechanisms & Immune cells in cancer. The author has an h-index of 2, co-authored 6 publications.
Papers by this author
worksSynthetic Disaggregators Enhance Central‐Peripheral Amyloid‐β Clearance in Alzheimer's Disease
2026 · Advanced Materials · 0 citations
https://doi.org/10.1002/adma.202520002
Synthetic cleavage-resistant TREM2 boosts macrophage efferocytosis to treat inflammatory diseases
2026 · Cell Reports Medicine · 0 citations
https://doi.org/10.1016/j.xcrm.2025.102580
Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice
2026 · Journal of Controlled Release · 0 citations
https://doi.org/10.1016/j.jconrel.2026.114710
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat